×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Klinisch relevante Arzneimittelinteraktionen - akdae.de · Spironolacton bei Herzinsuffizienz NYHA III/IV (RALES) N = 822 NYHA III und IV, EF < 35 % zusätzlich zu ACE-Hemmer, Diuretika,
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form